CHYM(CHYM)
CHYM
Q3 2026 EPS Estimate
$-0.01
Aug 6, 2026 · Reports before open
Revenue Estimate
$640M
FY2026E EPS$0.32
FY2027E EPS$0.76
Analyst Sentiment
Wall St. Consensus
Buy9 analysts·Limited coverage
72
Score
8 Buy (89%)1 Hold (11%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
889%
Hold
111%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$26.00
+16.7%
Consensus
$29.50
+32.4%
Bull
$31.00
+39.1%
12-Month Target Range9 analysts
$26.00$29.50$31.00
Current $22.28Consensus
Current Price
$22.28
Upside to Consensus
$7.22
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+19.19%
EPS+137.73%
FY2028
Rev+17.14%
EPS+51.42%
FY2029
Rev+21.64%
EPS+84.98%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $2.68B | $3.20B | $3.75B | $4.56B |
| Low | $2.67B | $3.12B | $3.73B | $4.47B |
| High | $2.69B | $3.27B | $3.76B | $4.66B |
| EBITDA Avg | $-745M | $-888M | $-1.04B | $-1.27B |
| Low | $-748M | $-908M | $-1.04B | $-1.29B |
| High | $-742M | $-866M | $-1.04B | $-1.24B |
| EBIT Avg | $-776M | $-925M | $-1.08B | $-1.32B |
| Low | $-779M | $-945M | $-1.09B | $-1.35B |
| High | $-773M | $-902M | $-1.08B | $-1.29B |
| Net Income Avg | $129M | $308M | $419M | $825M |
| Low | $95M | $203M | $304M | $804M |
| High | $157M | $505M | $582M | $849M |
| EPS Avg | $0.32 | $0.76 | $1.15 | $2.13 |
| Low | $0.24 | $0.52 | $0.78 | $2.07 |
| High | $0.40 | $1.30 | $1.50 | $2.19 |
| Analysts (Rev / EPS) | 15 / 12 | 15 / 12 | 11 / 8 | 5 / 6 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $669M | $724M | $772M | $768M | $802M | $860M | $914M | $904M |
| Low | $663M | $715M | $763M | $758M | $792M | $849M | $903M | $893M |
| High | $676M | $734M | $782M | $777M | $812M | $871M | $926M | $915M |
| EBITDA Avg | $-186M | $-201M | $-215M | $-213M | $-223M | $-239M | $-254M | $-251M |
| Low | $-188M | $-204M | $-217M | $-216M | $-226M | $-242M | $-257M | $-254M |
| High | $-184M | $-199M | $-212M | $-211M | $-220M | $-236M | $-251M | $-248M |
| EBIT Avg | $-194M | $-210M | $-223M | $-222M | $-232M | $-249M | $-264M | $-261M |
| Low | $-196M | $-212M | $-226M | $-225M | $-235M | $-252M | $-268M | $-265M |
| High | $-192M | $-207M | $-221M | $-219M | $-229M | $-246M | $-261M | $-258M |
| Net Income Avg | $24M | $54M | $86M | $51M | $79M | $106M | $155M | $101M |
| Low | $5M | $53M | $84M | $51M | $78M | $105M | $152M | $100M |
| High | $38M | $55M | $87M | $52M | $81M | $108M | $157M | $103M |
| EPS Avg | $0.06 | $0.14 | $0.21 | $0.13 | $0.20 | $0.27 | $0.39 | $0.25 |
| Low | $0.01 | $0.13 | $0.21 | $0.13 | $0.20 | $0.26 | $0.38 | $0.25 |
| High | $0.09 | $0.14 | $0.22 | $0.13 | $0.20 | $0.27 | $0.39 | $0.26 |
| Analysts (Rev / EPS) | 12 / 9 | 11 / 7 | 6 / 3 | 6 / 3 | 6 / 4 | 6 / 3 | 6 / 4 | 5 / 4 |